Findings from a recent study published in the journal JAMDA demonstrate that antipsychotic medications increase the risk of death in patients with Parkinson’s disease psychosis (PDP). In the study entitled “Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People…
In a recent study published in the journal Molecular Neurodegeneration, a team of researchers from the Imperial College London and Newcastle University developed a new non-invasive technique that is able to improve symptoms of Parkinson’s disease (PD) in rats. Parkinson’s disease is neurodegenerative disorder that mainly affects neurons that…
The country’s first coordinated initiative geared towards enhancing the holistic health of women diagnosed with Parkinson’s disease was officially launched last week by the Parkinson’s Disease Foundation (PDF) during a 3-day conference held in Florham Park, New Jersey. The Women and PD Initiative was created because of the underrecognized clinical needs of…
Ultra-athlete Sam Fox went through three long and back-breaking months, hiking, climbing and biking across the United States, all for the sake of raising awareness and funds for Parkinson’s disease through The Michael J. Fox Foundation for Parkinson’s Research, and in honor of his own mother, Lucy, who’s been living…
Results from a recent study published in the journal Parkinsonism & Related Disorders showed that individuals with Parkinson’s disease (PD) may want to consider preform everyday activities such as dish washing, laundry folding and strolls around the neighborhood, in an effort to better to control their disease symptoms.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company specialized in the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, has just announced it has filed for a New Drug Application with the US Food and Drug Administration for NUPLAZID (pimavanserin) for the treatment of psychosis associated…
Neuroscientists from the University of Adelaide are leading a first-of-its-kind study on a type of dementia commonly observed in patients with Parkinson’s disease, which the scientists hope lead to a potential new therapy. From September 1-7, 2015, during the Parkinson’s Awareness Week, the University of Adelaide’s School of Medicine’s Dr. Lyndsey Collins-Praino will be…
The National Parkinson Foundation’s (NPF) medical director, Michael S. Okun, M.D., recently published a new book, titled, “10 Breakthrough Therapies for Parkinson’s Disease,” which is a follow-up of his previous Amazon bestseller “Parkinson’s Treatment: 10 Secrets to a Happier Life.” The sequel provides updated information to patients and their…
The Lawson Health Research Institute recently signed a licensing agreement with STEMCELL Technologies to transfer international exclusive rights to commercialize innovative tools for Parkinson’s Disease research. STEMCELL Technologies provides more than 2,000 products to over 70 countries worldwide, including cell culture reagents, instruments and tools designed to support science along the basic to translational…
The battle against Parkinson’s disease may be getting sweeter, with a new study underway seeking to understand if concentrated chocolate supplements could help alleviate the disease’s symptoms. A team of researchers from Dresden University of Technology, Germany, are busy conducting tests on 30 participants to further understand the benefits of phenylethylamine, a compound found…
Get regular updates to your inbox.